CCND1 and hepatocellular carcinoma: In hepatocellular carcinoma cells, Oct3/4 was shown to upregulate BIRC5 (survivin) and CCND1 expression by increasing their promoter activity, thereby promoting cell proliferation and resisting cell apoptosis [75].